You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
A股收評:三大指數漲跌不一,創業板指跌1.39%,地產板塊領漲,醫藥股全面回調

3月22日,兩市主要指數漲跌不一,滬指在金融、地產股支撐下實現五連升,全天收漲0.19%報3259點,深成指、創業板指分別跌0.49%、1.39%。兩市1950股上漲,2560股下跌,成交額9600億元,北上資金淨賣出9.2億元。 

行業板塊多數上漲,醫藥股領跌兩市,強勢題材新冠藥概念重挫,芯片、光伏等概念跌幅靠前。地產股大漲,陽光城等十餘股漲停,萬科漲逾4%;煤炭、石油等礦產資源股大漲,中國石油、中國神華漲約3%;保險、銀行股集體上漲,平安銀行漲逾4%;培育鑽石、黃金、豬肉、數字貨幣等概念活躍。

醫藥股全線回調,其中新冠治療板塊跌幅居前。海辰藥業跌逾15%,諾泰生物跌逾12%,雅本化學跌逾11%,塞倫生物跌逾10%,凱因科技跌逾9%,普洛藥業、華海藥業、科興製藥、賽升藥業跌逾8%。

新冠檢測板塊跟隨走弱。北化股份跌停,萬孚生物跌逾9%,賽升藥業、仟源醫藥、博拓生物跌逾8%。

消息面上,截至3月17日,已有14家款新冠抗原檢測試劑獲批在國內上市。據瞭解,中國有超過400家的生產企業,有能力出口抗原檢測試劑產品。此外,多地已經開始集採,價格已被壓低,3月16日在山東省主導的魯晉兩省聯合採購中,抗原檢測最低價是每人份7.9元。

CRO概念股多數下挫。諾泰生物跌逾12%,誠達藥業、九州藥業跌逾7%,聖諾生物跌逾6%,藥石科技跌逾5%。

房地產板塊漲幅居前,多股漲停。光大嘉寶、中南建設、陽光城、萬通發展、嘉凱城、華夏幸福漲停,天保基建、信達地產逼近漲停。

消息面上,央行主管媒體《中國金融時報》刊文稱,近一段時間以來,政策暖風頻吹,“穩”的信號十分明顯。專家認為,隨着針對房地產信貸和需求端的支持政策進一步落地生效,房地產市場將加速回暖。

煤炭板塊表現強勢。昊華能源漲停,山西焦煤漲超7%,兗礦能源、中煤能源、晉控煤業、蘭花科創漲超4%。

 海通證券指出,從1-2月數據看,煤炭產量增幅遠高於需求增速,但煤價依然穩中有升,反映供需整體仍偏緊。考慮到全球煤炭資源緊張、俄烏局勢等情況,能源安全必將得到進一步重視,因此增產保供基調或貫穿全年,預計全年煤炭產量增速在去年高基數情況下仍有望穩健增長。

油氣板塊表現活躍。淮油股份漲停,仁智股份逼近漲停,中曼石油漲超5%,廣匯能源漲超4%。

消息面上,歐盟各國政府將考慮對俄羅斯實施石油禁運,國際油價走高,WTI原油期貨報112.9美元/桶,布倫特原油期貨報114.97美元/桶。

恆大概念股走強。廣田集團、友邦吊頂、國機汽車、皮阿諾、寶鷹股份漲停。

消息面上,中國恆大集團連同其財務顧問將在今晚的21時召開投資者電話會,參與會議的人員有中國恆大集團執行董事蕭紹恩、非執行董事梁森林以及風險管理委員會委員陳勇。

高鐵板塊集體上漲。通業科技、輝煌科技、威奧股份、祥和實業漲停,晉億實業、神州高鐵漲超9%。

大金融板塊一掃昨日頹勢,集體上揚。其中銀行板塊漲幅居前。南京銀行、平安銀行、成都銀行漲超4%,江蘇銀行漲超3%。

個股異動方面,中國東航跌逾6%,報5.34元。消息面上,東航一架波音737飛機21日在廣西梧州墜毀,機上人員共132人。現場發現了客機殘骸和碎片,但目前尚未發現機上失聯人員。

北向資金方面,北上資金淨流入27.22億元,其中滬股通淨流入12.63億元,深股通淨流入14.59億元。

展望後市,東興證券建議抓緊反彈期主動佈局。行業配置看三條主線:一是“穩增長”政策方向不改,關注基建鏈和金融地產。基建是宏微觀數據一致指向復甦的方向,且3月16日各部委會議也在紛紛釋放“穩地產”政策信號。;二是俄烏衝突導致全球資源品價格上漲,部分資源品的國內外價差明顯。國內生產企業有望受益,包括鋁和煤炭;三是部分成長股跌出了價值。在情緒修復、流動性改善的環境下,部分高景氣的成長股已足夠便宜。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account